Gilead’s Remdesivir set to become Europe’s first COVID-19 therapy

Gilead’s Remdesivir set to become Europe’s first COVID-19 therapy

Doctors in Europe will soon be able to treat COVID-19 patients with Gilead’s antiviral drug, remdesivir, after the healthcare regulator’s endorsement put it on track to become the first therapy for t…
Read More

Leave a Reply